Smart Pills Market growth, technology Advancements, demand and Market Size

Global Smart Pills Market: Information by Application (Patient Monitoring and Others), Target Area (Esophagus, Small Intestine, and Others), Disease Indication (Disease Indication, and Others) End User (Hospitals and Others)—Global Forecast till 2023

The global smart pills market accounts for USD 1,800 million and expected to register healthy CAGR ~14.2% during the forecast period.

According to the National Diabetes Statistics Report published by Centers for Disease Control and Prevention, in 2015, In the US 1.5 million new cases of diabetes were registered and approximately USD 245 billion spent on diagnosis and treatment of diabetes





Smart pills are small capsule-sized ingestible medical devices. Smart pills are used for diagnosis, treatment, and drug delivery. The growing geriatric population and with-it increasing diseases like paralysis are responsible for increasing demand for on-site diagnosis, increasing cases of chronic diseases like diabetes, cancer, and others, and rising prevalence of  lifestyle disorders such as obesity, gastroesophageal reflux disease (GERD), and  gastric ulcers are expected to drive the growth of the market.

Market Driving Key Players

Some of the key players in the global smart pills market are Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., MEDTRONIC, FUJIFILM Holdings Corporation, RF Co., Ltd., Check-Cap, BDD Limited, JINSHAN Science & Technology, MEDISAFE, PENTAX Medical, and INTROMEDIC.

The increasing government restrictions, stringent regulatory authorities, and high cost associated with smart pills may hamper the growth of the market during the assessment period.

Global Smart Pills Market Has Been Segmented On The Basis Of Application, Target Area, Disease Indication, And End-User.
On the basis of application, the market has been classified capsule endoscopy, drug delivery, patient monitoring, and others. 

The capsule endoscopy segment has been further divided into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. Patient monitoring segment has been divided into capsule pH monitoring and others.

Smart pills on the basis of the target area have been segmented into esophagus, small intestine, large intestine, and stomach.

The disease indication segment is divided into esophageal diseases, small bowel diseases, colon diseases, and others.

The market, by end-user, has been segmented into hospitals, diagnostic center, and research institute.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Comments

Popular Posts